Important Safety Information
As with any medical procedure, treatment with Kanexthal may involve potential side effects and complications. Most are temporary and manageable under close medical supervision. All steps of the manufacturing process, from cell collection to infusion, are conducted in quality facilities to ensure the highest safety and quality standards. The most common side effects of Kanexthal are:
Hematological effects:
• Lowered white blood cell count
• Decreased neutrophil count
• Decreased platelet count
Non-hematological effects:
• Hypokalemia
• Vomiting
• Oral mucositis
• Febrile neutropenia
Talk to your physician regarding those possible side effects. Your healthcare provider may give you other medicines to treat your side effects accordingly. It is important that you have regular check-ups with your healthcare provider, including at a minimum annual blood tests, to detect any adverse effects and to confirm that Kanexthal is still working.
Serious Adverse Events
To date, no insertional mutagenesis, clonal expansion, or replication-competent retrovirus (RCL)–related events have been observed in patients treated with Kanexthal.
Safety Monitoring
Safety is monitored continuously throughout the treatment process to ensure that every patient is provided with the most adequate care.
Risk Mitigation
To minimize risks, patients are:
-
Carefully screened and prepared before treatment
-
Closely monitored during hospitalization
-
Supported by an experienced medical team throughout recovery
This page provides general education information. Side effects and risks can vary. Please consult your qualified healthcare professionals for individualized guidance and additional information.